Cashu
Novartis AG: Leading Innovative Drug Development with Focus on Gene Therapies and Precision Medicine
about 20 hours ago
Stocks
Health Care
nvs
Novartis AG
SWISS EXCHANGE: NVS
-1.98 (0.00%)
130.18
USD
At close at Dec 09, 14:26 UTC
Latest Novartis AG News
benzinga.com
Price Over Earnings Overview: Novartis
4 days ago
benzinga.com
What's Going On With Arrowhead Shares Wednesday?
13 days ago
benzinga.com
FDA OKs Novartis SMA Treatment As First Gene Therapy Option For Kids, Teens And Adults
14 days ago
prnewswire.com
Novartis receives FDA approval for Itvisma, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)
15 days ago
benzinga.com
Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts
19 days ago
benzinga.com
Is the Market Bullish or Bearish on Novartis AG?
21 days ago
benzinga.com
Is AI The Key To Beating Cancer? Why Pharma Stocks Are Soaring
22 days ago
benzinga.com
Trump's Bond Buying Spree Surges Past $82 Million Since August
23 days ago
benzinga.com
Trump Unveils $200 Billion Trade Deal With Switzerland And Liechtenstein To Cull $38.5 Billion US Goods Deficit By 2028
24 days ago
benzinga.com
Novartis' Investigational Medicine Shows Potent Activity Against Drug-Resistant Malaria Strains
26 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.